The current valuation score of Minerva Neurosciences Inc is 8.93, ranking 69 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.12, which is -12098.13% below the recent high of 14.10 and -5071.40% above the recent low of -6.08.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.